Benoit Adam
About Benoit Adam
Benoit Adam is a Program Director at IBA, where he has worked since 2019, overseeing the development of the Proteus235 proton therapy product. With over two decades of experience in proton therapy and a background in engineering, he has held various roles at IBA and previously at Lucent Technologies.
Current Role as Program Director
Benoit Adam has been serving as Program Director at IBA since 2019. In this role, he oversees the development of the Proteus235, a proton therapy product. His responsibilities include managing complex product development programs within the medical technology sector. His extensive experience in this field contributes to the advancement of proton therapy.
Previous Experience at IBA
Benoit Adam has held multiple positions at IBA. He worked as R&D Development / Project Manager from 2001 to 2006, followed by a role as Services Engineering Manager from 2007 to 2009. He then served as R&D Director - Proton Therapy System Development Program Manager from 2009 to 2019. His tenure at IBA spans over 15 years, during which he has significantly contributed to the development and management of proton therapy.
Experience at Lucent Technologies
Before his extensive career at IBA, Benoit Adam worked as a Systems Engineer at Lucent Technologies from 1996 to 2001. This role provided him with foundational experience in engineering and technology, which he later applied in the medical technology sector.
Educational Background
Benoit Adam studied at Institut Supérieur Industriel D'arlon from 1981 to 1983, followed by further studies at Institut Supérieur Industriel De Bruxelles from 1983 to 1985. His education laid the groundwork for his career in engineering and technology.
Expertise in Proton Therapy
Benoit Adam has over two decades of experience in the field of proton therapy. His contributions to its development and management have been significant, reflecting his expertise in this specialized area of medical technology.